Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA12 | O43570 | 2/20 | 0.47 |
| ▸ | ALPL | P05186 | 1/20 | 0.47 |
| ▸ | PDPK1 | O15530 | 1/20 | 0.42 |
| ▸ | HSP90AB1 | P08238 | 1/20 | 0.42 |
| ▸ | FGFR1 | P11362 | 2/20 | 0.41 |
| ▸ | FGFR2 | P21802 | 2/20 | 0.41 |
| ▸ | FGFR3 | P22607 | 1/20 | 0.41 |
| ▸ | DHODH | Q02127 | 2/20 | 0.39 |
| ▸ | MAP2K4 | P45985 | 3/20 | 0.38 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.38 |
| ▸ | MAPKAPK2 | P49137 | 2/20 | 0.38 |
| ▸ | MAPK6 | Q16659 | 2/20 | 0.38 |
| ▸ | MAPKAPK3 | Q16644 | 1/20 | 0.38 |
| ▸ | MAPKAPK5 | Q8IW41 | 1/20 | 0.38 |
| ▸ | MEN1 | O00255 | 2/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.38 |
| ▸ | MAPT | P10636 | 2/20 | 0.38 |
| ▸ | NPC1 | O15118 | 1/20 | 0.38 |
| ▸ | USP2 | O75604 | 1/20 | 0.38 |
| ▸ | TP53 | P04637 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23328966 | 0.91 | MAP2K4 (0.41) | CA12ALPLMAP2K4MAPK1MAPK6 | |
| SCHEMBL23294375 | 0.86 | MAP2K4 (0.45) | ALPLDHODHMAP2K4MAPK1MAPK6 | |
| SCHEMBL23294477 | 0.86 | MAP2K4 (0.45) | ALPLDHODHMAP2K4MAPK1MAPK6 | |
| SCHEMBL15946998 | 0.85 | KDM4E (0.46) | ALPLMAP2K4MAPK1MAPK6MAPKAPK3 | |
| SCHEMBL23294606 | 0.84 | ALPL (0.49) | ALPLMAP2K4MAPK1MAPKAPK2MAPK6 | |
| SCHEMBL14705874 | 0.84 | HAO1 (0.49) | CA12ALPLMAP2K4MAPK1MAPK6 | |
| SCHEMBL23294603 | 0.84 | HAO1 (0.49) | CA12ALPLMAP2K4MAPTHAO1 | |
| Hydrochloric Acid SCHEMBL3527570 | 0.84 | KDM4E (0.44) | ALPLMAP2K4MAPK1MAPK6MAPKAPK3 | |
| SCHEMBL23294326 | 0.83 | MCL1 (0.41) | DHODHMAP2K4MAPK1MAPTTP53 | |
| SCHEMBL23294600 | 0.83 | ALPL (0.47) | ALPLDHODHMAP2K4MAPK1MAPKAPK2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3241075-B1 | STRIPPING COMPOSITIONS FOR REMOVING PHOTORESISTS FROM SEMICONDUCTOR SUBSTRATES | FUJIFILM ELECTRONIC MAT USA INC (US) | 2024-10-16 | — | — | EP | disclosed |
| CN-107850859-B | Stripping composition for removing photoresist on semiconductor substrate | 富士胶片电子材料美国有限公司 | 2021-06-01 | — | — | CN | disclosed |
| CN-107850859-A | Stripping composition for removing photoresist on semiconductor substrate | 富士胶片电子材料美国有限公司 | 2018-03-27 | — | — | CN | disclosed |
| US-9914902-B2 | Stripping compositions for removing photoresists from semiconductor substrates | FUJIFILM ELECTRONIC MATERIALS U.S.A., INC. (US) | 2018-03-13 | — | — | US | disclosed |
| EP-3241075-A1 | STRIPPING COMPOSITIONS FOR REMOVING PHOTORESISTS FROM SEMICONDUCTOR SUBSTRATES | FujiFilm Electronic Materials USA, Inc. (US) | 2017-11-08 | — | — | EP | disclosed |
| US-20160186106-A1 | STRIPPING COMPOSITIONS FOR REMOVING PHOTORESISTS FROM SEMICONDUCTOR SUBSTRATES | FUJIFILM ELECTRONIC MATERIALS U.S.A., INC. | 2016-06-30 | — | — | US | disclosed |
| CN-101203518-B | Fluorene derivative, composition containing the same and use thereof | AVENTIS PHARMA SA | 2013-07-24 | — | — | CN | disclosed |
| US-7674795-B2 | Fluorene derivatives, composition containing said derivatives and the use thereof | AVENTIS PHARMA SA (FR) | 2010-03-09 | — | — | US | disclosed |
| US-20080153837-A1 | Novel Fluorene Derivatives, Composition Containing Said Derivatives and the Use Thereof | AVENTIS PHARMA S.A. (FR) | 2008-06-26 | — | — | US | disclosed |
| CN-101203518-A | Novel fluorene derivatives, compositions containing same and uses thereof | AVENTIS PHARMA SA (FR) | 2008-06-18 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080153837-A1 | Novel Fluorene Derivatives, Composition Containing Said Derivatives and the Use Thereof | HSP90B1, HSP90AB1, HSP90AA1 | CA12 4741/4885ALPL 4718/4885PDPK1 1460/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.